Can CorMedix (CRMD) Keep the Earnings Surprise Streak Alive?

Core Viewpoint - CorMedix (CRMD) is positioned to potentially continue its earnings-beat streak in upcoming reports, having surpassed earnings estimates consistently in recent quarters [1][5]. Earnings Performance - In the last reported quarter, CorMedix achieved earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.25 per share, resulting in a surprise of 20.00% [2]. - In the previous quarter, the company was expected to report earnings of $0.17 per share but delivered $0.22 per share, leading to a surprise of 29.41% [2]. Earnings Estimates and Predictions - Estimates for CorMedix have been trending higher, attributed to its history of earnings surprises, with a current Earnings ESP of +20.00%, indicating a bullish outlook from analysts [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong possibility of another earnings beat [8]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7].